home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Overview On 2006 Sales Of TOP 20 Biologics To Be Released On February 26

  February, 5 2007 16:24
your information resource in human molecular genetics
BARCELONA, Spain | Feb 02, 2007 | The Business Intelligence firm La Merie S.L. announced that it will release the second edition of its compilation of the sales of “TOP 20 Biologics”, now fro 2006, on February 26, 2007. The compilation contains 2006 sales and growth rates of the single best selling biologic products and of classes of therapeutic biologics (recombinant antibodies and proteins & peptides). The product can be obtained as a free download on the website www.pipelinereview.com starting February 26 or by free e-mail delivery. For more details please visit La Merie’s News Center and Online Store www.pipelinereview.com

About La Merie

La Merie S.L. is a Business Intelligence enterprise fully dedicated to provide high quality R&D information to the biopharmaceutical industry. La Merie offers individual consultancy services and publishes reports and periodicals. For more information visit www.lamerie.com.

About PipelineReview.com

PipelineReview.com is the News Center and Online Store of La Merie Business Intelligence focused on Research and Development in the Biopharmaceutical Industry. Visitors of PipelineReview.com will find R&D relevant press releases and can receive selected R&D news from one or more of the site’s News Channels. A free R&D Newletter conveniently brings via e-mail a daily selection of the most interesting news from biopharmaceutical R&D. For more information visit www.pipelinereview.com

About TOP 20 Biologics 2006

As in the previous year, La Merie Business Intelligence provides an analysis of the top selling recombinant antibodies and proteins of the past full year. The compilation will list the TOP 20 Biologics and rank the commercially most successful classes of biologic products (excluding vaccines). In addition, a list of the TOP 10 biologics selling companies will be presented. The compilation "TOP 20 Biologics" can be acquired as a free download or by e-mail delivery. For more details please visit www.pipelinereview.com

SOURCE: La Merie Business Intelligence

Message posted by: Jorge Márquez

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.